Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Hoffmann

Showing results (41-50 of 81) with videos related to

Pageof 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
Comparative profiling of the novel epothilone, sagopilone, in xenografts derived from primary non-small cell lung cancerStefanie Hammer, Anette Sommer, Iduna Fichtner, et al.
Scientific Data|November 19, 2022
So2Sat POP - A Curated Benchmark Data Set for Population Estimation from Space on a Continental ScaleSugandha Doda, Yuanyuan Wang, Matthias Kahl, et al.
Neuro-Oncology|September 11, 2008
Sagopilone crosses the blood-brain barrier in vivo to inhibit brain tumor growth and metastasesJens Hoffmann, Iduna Fichtner, Margit Lemm, et al.
NMR in Biomedicine|July 4, 2020
Feasibility of precise and reliable glucose quantification in human whole blood samples by 1 tesla benchtop NMRMichael Stolz, Carolin Schlawne, Jens Hoffmann, et al.
Chembiochem : a European Journal of Chemical Biology|March 16, 2007
Cloning and heterologous expression of the aranciamycin biosynthetic gene cluster revealed a new flexible glycosyltransferaseAndriy Luzhetskyy, Almuth Mayer, Jens Hoffmann, et al.
Cancers|December 10, 2021
Modeling of Personalized Treatments in Colon Cancer Based on Preclinical Genomic and Drug Sensitivity DataMarlen Keil, Theresia Conrad, Michael Becker, et al.
International Journal of Cancer|June 1, 2017
Basal subtype is predictive for response to cetuximab treatment in patient-derived xenografts of squamous cell head and neck cancerKonrad Klinghammer, Raik Otto, Jan-Dirk Raguse, et al.
Advances in Biological Regulation|December 6, 2021
Rapid testing of candidate oncogenes and tumour suppressor genes in signal transduction and neoplastic transformationSha Liu, Paula Medina-Perez, Minh-Cam Ha-Thi, et al.
Plos One|October 4, 2019
RPL22L1 induction in colorectal cancer is associated with poor prognosis and 5-FU resistanceShuyun Rao, Suraj Peri, Jens Hoffmann, et al.
Oncotarget|October 28, 2020
Combination of copanlisib with cetuximab improves tumor response in cetuximab-resistant patient-derived xenografts of head and neck cancerKonrad Klinghammer, Oliver Politz, Theresa Eder, et al.
Pageof 9

Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
Comparative profiling of the novel epothilone, sagopilone, in xenografts derived from primary non-small cell lung cancerStefanie Hammer, Anette Sommer, Iduna Fichtner, et al.
Scientific Data|November 19, 2022
So2Sat POP - A Curated Benchmark Data Set for Population Estimation from Space on a Continental ScaleSugandha Doda, Yuanyuan Wang, Matthias Kahl, et al.
Neuro-Oncology|September 11, 2008
Sagopilone crosses the blood-brain barrier in vivo to inhibit brain tumor growth and metastasesJens Hoffmann, Iduna Fichtner, Margit Lemm, et al.
NMR in Biomedicine|July 4, 2020
Feasibility of precise and reliable glucose quantification in human whole blood samples by 1 tesla benchtop NMRMichael Stolz, Carolin Schlawne, Jens Hoffmann, et al.
Chembiochem : a European Journal of Chemical Biology|March 16, 2007
Cloning and heterologous expression of the aranciamycin biosynthetic gene cluster revealed a new flexible glycosyltransferaseAndriy Luzhetskyy, Almuth Mayer, Jens Hoffmann, et al.
Cancers|December 10, 2021
Modeling of Personalized Treatments in Colon Cancer Based on Preclinical Genomic and Drug Sensitivity DataMarlen Keil, Theresia Conrad, Michael Becker, et al.
International Journal of Cancer|June 1, 2017
Basal subtype is predictive for response to cetuximab treatment in patient-derived xenografts of squamous cell head and neck cancerKonrad Klinghammer, Raik Otto, Jan-Dirk Raguse, et al.
Advances in Biological Regulation|December 6, 2021
Rapid testing of candidate oncogenes and tumour suppressor genes in signal transduction and neoplastic transformationSha Liu, Paula Medina-Perez, Minh-Cam Ha-Thi, et al.
Plos One|October 4, 2019
RPL22L1 induction in colorectal cancer is associated with poor prognosis and 5-FU resistanceShuyun Rao, Suraj Peri, Jens Hoffmann, et al.
Oncotarget|October 28, 2020
Combination of copanlisib with cetuximab improves tumor response in cetuximab-resistant patient-derived xenografts of head and neck cancerKonrad Klinghammer, Oliver Politz, Theresa Eder, et al.
Pageof 9